ERBB2 and neoplasm: A retrospective cohort study including 602 patients revealed that factors such as age, menopausal status, tumor size, histologic grading, hormone receptor status, HER-2 status, and lymphovascular invasion did not act as independent predictors for non-SLN metastasis [30].